Pulse Biosciences, Inc. (PLSE) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cerus Corp.

NeuroPace, Inc.

Sanara MedTech, Inc.

AngioDynamics, Inc.

ZimVie, Inc.

Anika Therapeutics, Inc.

AVITA Medical, Inc.

Accuray, Inc.

Zynex, Inc.

Pulse Biosciences, Inc.

Alpha Tau Medical Ltd.

Why is Pulse Biosciences, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Pulse Biosciences, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Pulse Biosciences, Inc.

30.89%

0.97

82.69%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.19%

EBIT Growth (5y)

-14.37%

EBIT to Interest (avg)

-52.89

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.00

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

10.68%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

18.40

EV to EBIT

-18.26

EV to EBITDA

-18.52

EV to Capital Employed

942.35

EV to Sales

1405.04

PEG Ratio

Dividend Yield

ROCE (Latest)

-5160.23%

ROE (Latest)

-90.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

NET SALES(9M)

At USD 0.35 MM has Grown at inf%

NET PROFIT(HY)

Higher at USD -36.82 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 2.55 times

-7What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -54.13 MM

NET PROFIT(9M)

At USD -55.99 MM has Grown at -34.74%

RAW MATERIAL COST(Y)

Grown by 9,659% (YoY

Here's what is working for Pulse Biosciences, Inc.

Net Sales

At USD 0.35 MM has Grown at inf%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Net Profit

Higher at USD -36.82 MM

than preceding 12 month period ended Dec 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debtors Turnover Ratio

Highest at 2.55 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Pulse Biosciences, Inc.

Operating Cash Flow

Lowest at USD -54.13 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Raw Material Cost

Grown by 9,659% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales